The Association of American Cancer Institutes (AACI) comprises 103 premier academic and freestanding cancer centers in the United States and Canada. AACI is accelerating progress against cancer by empowering North America's leading cancer centers in their shared mission to alleviate suffering.
Acting as a network for research leaders, Clinical Research Innovation (CRI) promotes the efficient operation of clinical research facilities at AACI cancer centers.
The AACI Government Relations Forum facilitates an improved understanding of policy issues as they pertain to cancer prevention, treatment, and survivorship.
Caryn Lerman, PhD, is the director of University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles and the associate dean for cancer programs and the H. Leslie and Elaine S. Hoffman Professor in Cancer Research at Keck School of Medicine of USC. She joined the AACI Board of Directors in 2019 and was elected vice president/president-elect in 2020.
Dr. Lerman’s experience in cancer center leadership spans more than 20 years. Internationally recognized for cancer prevention research that bridges the fields of genomics, pharmacology, and population science, she has deep knowledge of multiple frameworks of cancer discovery and innovation from basic and translational/clinical science to population-based research and biotechnology. A major focus of her research is on biology-driven science to reduce cancer risk behaviors.
The AACI Presidential Initiative allows the president of AACI's Board of Directors to formalize a special project of broad interest and value to AACI members during their two-year term.
Caryn Lerman, PhD, will formally present plans for her presidential initiative at the 2021 AACI/CCAF Annual Meeting in October. Dr. Lerman's initiative will focus on leadership development with an emphasis on diversity.